TY - JOUR
T1 - Cardiac metastasis in a patient with clear cell renal cell carcinoma who underwent multimodality therapy for multiple metastases after radical nephrectomy
AU - Takeuchi, Shinichi
AU - Mizutani, Kosuke
AU - Iinuma, Koji
AU - Muramatsu-Maekawa, Yuka
AU - Horie, Kengo
AU - Kato, Taku
AU - Nakane, Keita
AU - Tsuchiya, Tomohiro
AU - Nakano, Masahiro
AU - Koie, Takuya
N1 - Publisher Copyright:
© 2019 Editorial Board of Acta Urologica Japonica. All rights reserved.
PY - 2019/6
Y1 - 2019/6
N2 - The patient underwent laparoscopic left radical nephrectomy for clear cell renal cell carcinoma (ccRCC). After surgery, the patient had multiple lung metastases and underwent the combination therapy of radiofrequency ablation, interferon-alpha, and inteleukin-2. Thereafter, computed tomography showed multiple lymph node and brain metastases. The patient was administered targeted therapy and radiation. Eventually, the patient suddenly complained of dyspnea. An echocardiogram, coronary angiography and magnetic resonance imaging suggested acute heart failure and pericardial effusion due to a metastatic tumor in the cardiac anteroseptal and posterior wall. Nivolumab was administered for cardiac metastases. The patient has been in stable condition with no progression of cardiac metastases after the administration of nivolumab for 22 months.
AB - The patient underwent laparoscopic left radical nephrectomy for clear cell renal cell carcinoma (ccRCC). After surgery, the patient had multiple lung metastases and underwent the combination therapy of radiofrequency ablation, interferon-alpha, and inteleukin-2. Thereafter, computed tomography showed multiple lymph node and brain metastases. The patient was administered targeted therapy and radiation. Eventually, the patient suddenly complained of dyspnea. An echocardiogram, coronary angiography and magnetic resonance imaging suggested acute heart failure and pericardial effusion due to a metastatic tumor in the cardiac anteroseptal and posterior wall. Nivolumab was administered for cardiac metastases. The patient has been in stable condition with no progression of cardiac metastases after the administration of nivolumab for 22 months.
UR - http://www.scopus.com/inward/record.url?scp=85071988100&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071988100&partnerID=8YFLogxK
U2 - 10.14989/ActaUrolJap_65_6_197
DO - 10.14989/ActaUrolJap_65_6_197
M3 - Article
C2 - 31501385
AN - SCOPUS:85071988100
SN - 0018-1994
VL - 65
SP - 197
EP - 201
JO - Acta Urologica Japonica
JF - Acta Urologica Japonica
IS - 6
ER -